TY - JOUR
KW - Adult
KW - Ambulatory Care/methods/trends
KW - Buprenorphine/administration & dosage
KW - Delayed-Action Preparations/administration & dosage
KW - Detoxification
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Injections, Intramuscular
KW - Male
KW - Middle Aged
KW - Naltrexone
KW - Naltrexone/administration & dosage
KW - Narcotic Antagonists/administration & dosage
KW - Opioid receptor antagonist
KW - opioid use disorder
KW - opioid withdrawal
KW - Opioid-Related Disorders/drug therapy/epidemiology/psychology
KW - Opioids
KW - Outpatients/psychology
KW - Patient Transfer/methods/trends
KW - Substance Withdrawal Syndrome/drug therapy/epidemiology/psychology
AU - A. Bisaga
AU - P. Mannelli
AU - M. Yu
AU - N. Nangia
AU - C. E. Graham
AU - D. A. Tompkins
AU - T. R. Kosten
AU - S. C. Akerman
AU - B. L. Silverman
AU - M. A. Sullivan
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CY - Ireland
DO - 10.1016/j.drugalcdep.2018.02.023
JF - Drug and alcohol dependence
PB - The Authors. Published by Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 171
EP - 178
EP - 
T1 - Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
T2 - Drug and alcohol dependence
TI - Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
U1 - Opioids & Substance Use
U2 - 29674251
U3 - 10.1016/j.drugalcdep.2018.02.023
VL - 187
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -